Despite apprehensions on the sample numbers of human trials, Russia is preparing a mass vaccination campaign against the novel coronavirus in October, after a vaccine completed clinical trials including Phase III trial on Saturday, August 1, 2020. Health Minister Mikhail Murashko said the Gamaleya Institute, a state research facility in Moscow, had completed clinical trials preparing the required paperwork to ...

As the coronavirus vaccine being developed by Oxford university and AstraZeneca enters the third phase of the trials, Serum Institute of India (SII) is geared up to procure a licence from the Indian regulator to start clinical trials in the country in a week’s time. Serum Institute of India, the largest vaccine manufacturer in the world, and a partner in ...

Finally, a Covid-19 vaccine developed by Oxford University’s Jenner Institute and licensed to the multinational pharmaceutical company, AstraZeneca has emerged as the favourite of World Health Organization scientists out of about 23 vaccines in their Phase III trial, after reporting success and safety in the first two phases. For India, this vaccine is important as AstraZeneca, among others, had entered ...